Myrafast Forte Tablets are a pharmaceutical formulation designed for multimodal pain relief, because every move matters. The formulation combines advanced anti-inflammatory, analgesic, and joint-supporting ingredients that act on multiple pain pathways, including COX-2, 5-LOX, CB-2, and μ-opioid receptors. This targeted mechanism helps reduce inflammation, relieve pain, and improve functional mobility with clinically observed improvements in pain scores and functional outcomes.
Myrafast Forte Tablets are a pharmaceutical formulation designed for multimodal pain relief, because every move matters. The formulation combines advanced anti-inflammatory, analgesic, and joint-supporting ingredients that act on multiple pain pathways, including COX-2, 5-LOX, CB-2, and μ-opioid receptors. This targeted mechanism helps reduce inflammation, relieve pain, and improve functional mobility with clinically observed improvements in pain scores and functional outcomes.
Acute and chronic musculoskeletal pain Osteoarthritis and inflammatory arthritis Joint pain, stiffness, and reduced mobility Inflammatory conditions associated with elevated pain markers
As directed by the physician
MSM (Methylsulfonylmethane) – 500 mg Aflapin® (Boswellia serrata extract) – 50 mg Commiphora myrrha (MyrLiq®) – 100 mg Curcuma longa extract (CurQlife®) – 100 mg Beta Caryophyllene – 100 mg Boron – 3 mg
MSM Inhibits the COX-2 pathway, reducing prostaglandin-mediated inflammation and pain Aflapin® Inhibits the 5-LOX pathway, decreasing leukotriene-driven chronic inflammation Commiphora myrrha (MyrLiq®) Modulates inflammatory mediators Supports reduction of pain and joint stiffness CurQlife® Blocks pro-inflammatory cytokines Provides sustained anti-inflammatory and analgesic support Beta Caryophyllene Acts as a CB-2 receptor agonist Modulates immune-mediated pain and inflammation Boron Acts as a μ-opioid receptor agonist Enhances endogenous pain relief without dependency Combined Effect: The multimodal mechanism targets inflammation and pain at multiple biochemical pathways, resulting in faster pain relief, reduced inflammatory markers, and improved functional mobility.
